NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Prevention of the Selection of Resistant Staphylococcus aureus by Moxifloxacin Plus Doxycycline in an In Vitro Dynamic Model: an Additive Effect of the Combination.

FIRSOV A, VOSTROV S, LUBENKO I, DRLICA K, PORTNOY Y, ZINNER S; Interscience Conference on Antimicrobial Agents and Chemotherapy (43rd: 2003: Chicago, Ill.).

Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother. 2003 Sep 14-17; 43: abstract no. A-1148.

Gause Inst. of New Antibiotics, Moscow, Russian Federation.

Objective. Threshold ratios of the 24-h area under the curve (AUC) to the MIC that prevent the selection of resistant Staphylococcus aureus have been estimated at 200-240 h in our previous study with four quinolones. These AUC/MICs correspond to levels above the mutant prevention concentrations (MPCs), i.e., the upper border of the mutant selection window (MSW). Can this selection be prevented using the smaller AUC/MICs seen with antibiotic combinations? To test this hypothesis, changes in the susceptibility of S. aureus exposed to moxifloxacin (M; threshold AUC/MIC of 220 h), alone and in combination with doxycycline (D) were examined in an in vitro dynamic model. Methods. Once-daily administration of M and D were simulated for 5 consecutive days. The AUC/MIC ratios of M and D were designed to provide the summed AUC/MICs at which significant (60 h), moderate (90 h) and negligible (230 h) increases in MIC were expected. MICs of M and D for bacterial cultures sampled from the model were determined daily for 6 days. Results. Significant losses in susceptibility were observed with monotherapy where M or D concentrations fall into the MSW for most of the dosing interval (AUC/MIC 60 h). Less pronounced changes in MIC occurred when the ratios of summed concentrations of M (AUC/MIC 60 h) + D (30 h) or M (30 h) + D (60 h) to their MICs were lower than MPC/MIC for 55% of the dosing interval. No losses in susceptibility were associated with summed MIC-related concentrations of M (AUC/MIC 60 h) + D (170 h) or M (170 h) + D (60 h) when MPC/MIC was exceeded for the entire dosing interval. Conclusions. These data suggest that the total AUC/MIC of 230 h might protect against S. aureus resistance. As this value is close to that predicted with M monotherapy (220 h), an additive protective effect of M+D on the selection of resistant S. aureus is proposed.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Anti-Bacterial Agents
  • Area Under Curve
  • Aza Compounds
  • Doxycycline
  • In Vitro
  • Microbial Sensitivity Tests
  • Models, Biological
  • Quinolines
  • Quinolones
  • Selection (Genetics)
  • Staphylococcus aureus
  • genetics
  • moxifloxacin
Other ID:
  • GWAIDS0025764
UI: 102265388

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov